The U.K. is set to be the first country to allow over-the-counter sales of the erectile dysfunction drug Viagra, after the medication was reclassified.
Instead of going to see a doctor, men over the age of 18 will be able to obtain the drug after a conversation with a pharmacist. “Erectile dysfunction can be a debilitating condition, so it’s important men feel they have fast access to quality and legitimate care,” said Mick Foy of the Medicines and Healthcare products Regulatory Agency (MHRA), the body that made the decision. A four-pack of the drug, the formal name for which is Sildenafil, will cost around £20 ($27).
Pfizer, the U.S. pharmaceutical company that manufactures the drug, said it had plans to launch a non-prescription version of Viagra in spring 2018, according to Reuters.
The MRHA made the decision to deregulate the drug after a public consultation, and said it hoped the rule change would reduce the number of people buying counterfeit versions of the drug, which can be dangerous. The agency said that it had seized over £50m ($67m) of unlicensed and counterfeit erectile dysfunction medications in the past five years.
More Must-Reads from TIME
- Why Trump’s Message Worked on Latino Men
- What Trump’s Win Could Mean for Housing
- The 100 Must-Read Books of 2024
- Sleep Doctors Share the 1 Tip That’s Changed Their Lives
- Column: Let’s Bring Back Romance
- What It’s Like to Have Long COVID As a Kid
- FX’s Say Nothing Is the Must-Watch Political Thriller of 2024
- Merle Bombardieri Is Helping People Make the Baby Decision
Write to Billy Perrigo at billy.perrigo@time.com